Related Experiment Video
Updated: Jul 3, 2026
09:18
A Comparative Study of Drug Delivery Methods Targeted to the Mouse Inner Ear: Bullostomy Versus Transtympanic Injection
Published on: March 8, 2017
Steroids in otolaryngology
1Department of Otolaryngology, Head and Neck Surgery, St. Vincent's Hospital, Sydney, Australia.
The Laryngoscope
|August 5, 2008
Summary
Corticosteroids effectively manage several ear, nose, and throat conditions, including facial palsy and sinusitis. However, their use in Meniere
Area of Science:
- Otolaryngology
- Endocrinology
- Pharmacology
Background:
- Steroids are widely utilized for various otolaryngological conditions.
- Understanding steroid-related complications is crucial for ear, nose, and throat (ENT) surgeons.
- This review examines the efficacy and risks of steroid use in ENT practice.
Purpose of the Study:
- To review the role and applications of steroid therapy in common ear-nose-throat disorders.
- To evaluate the evidence supporting corticosteroid use in specific ENT conditions.
- To highlight areas where steroid efficacy is established versus controversial.
Main Methods:
- Literature review of studies on steroid use in otolaryngology.
- Analysis of clinical trial data and case reports.
- Synthesis of current evidence regarding corticosteroid efficacy and safety.
Main Results:
- Corticosteroids demonstrate effectiveness in treating idiopathic facial nerve palsy, allergic rhinitis, acute sinusitis, sinonasal inflammatory polyposis, and croup.
- Evidence supports steroid use for allergic rhinitis and sinusitis management.
- Therapeutic efficacy for Meniere's disease, sudden sensorineural hearing loss, chronic otitis media, and vestibular neuronitis remains debated.
Conclusions:
- Steroid therapy is a valuable tool for specific otolaryngological conditions.
- Further research is needed to clarify the role of steroids in controversial ENT disorders.
- ENT surgeons must weigh the benefits against potential complications of corticosteroid use.
Related Concept Videos
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
01:16Drugs Used in Upper Respiratory Disorders: Overview
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
01:17Drugs Used in Lower Respiratory Disorders: Overview
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...